Guidelines Call for More Transparency on Hepatitis C Drug Costs

Updated guidelines from the American Association for the Study of Liver Diseases, the Infectious Diseases Society of America and the International Antiviral Society -USA attempt to provide an overview of hepatitis C virus treatments, including cost comparisons. Learn more here, login required. (Source: Medscape, 8/26/15)

You might also be interested in:

New Non-Profit Association Launches Free Guideline… January 16, 2019
NICE Report: Cancer Drugs Priced According to Effectiveness… February 25, 2019
Levinson: Robust, Long-Term Transparency in Health Care… November 20, 2018
Research Suggests Low-Cost Generics at High Risk of Shortages December 14, 2018
Pharmacy Benefit Managers: A Mechanism for Containing Costs or… October 1, 2018
International Task Force Proposes Updated Definition of HTA March 26, 2019
Study Finds Success in Value-Based Oncology Model Dependent… October 28, 2018